FDA - Adverse Event Reporting System (AERS) Freedom Of Information (FOI) Report Date:02/26/01ISR Number: 3671177-0Report Type:Expedited (15-DaCompany Report #A102354 Age:34 YR Gender:Female I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Liver Function Test Foreign Zeldox PS Pfizer Medicinal Initial or Prolonged Abnormal Health Product Research And Pyrexia Professional Development ORAL 40.00 MG Respiratory Failure TOTAL:BID:ORA Viral Infection L Date:03/05/01ISR Number: 3674499-2Report Type:Expedited (15-DaCompany Report #A103693 Age: Gender:Female I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Death Death Foreign Zeldox PS Pfizer Medicinal Health Product Research And Professional Development ORAL ORAL Company Representative Date:03/06/01ISR Number: 3675422-7Report Type:Expedited (15-DaCompany Report #A100973 Age:47 YR Gender:Female I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Death Cholelithiasis Foreign Zeldox PS Pfizer Medicinal Completed Suicide Health Product Research And Decreased Appetite Professional Development ORAL 40.00 MG Depression TOTAL: BID: Fatigue ORAL Therapeutic Agent Fluoxetin SS Toxicity Propiomazin SS Uterine Leiomyoma Lithionit C Weight Decreased Bevitotal Comp C Alvedon C Losec Mups C Imovane C Apodorm C Date:03/06/01ISR Number: 3675430-6Report Type:Expedited (15-DaCompany Report #A104078 Age: Gender: I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Death Death Foreign Zeldox PS Pfizer Medicinal Health Product Research And Professional Development Company Representative Date:03/09/01ISR Number: 3678302-6Report Type:Expedited (15-DaCompany Report #A103833 Age: Gender:Male I/FU:F Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Suicide Attempt Foreign Zeldox PS Pfizer Medicinal Initial or Prolonged Health Product Research And Professional Development ORAL 80.00 MG 22-Feb-2006 08:32 AM Page: 1 FDA - Adverse Event Reporting System (AERS) Freedom Of Information (FOI) Report TOTAL:BID:ORA L Date:03/12/01ISR Number: 3680366-0Report Type:Expedited (15-DaCompany Report #A100973 Age:47 YR Gender:Female I/FU:F Outcome PT Report Source Product Role Manufacturer Route Dose Duration Death Cholecystitis Foreign Zeldox PS Pfizer Medicinal Cholelithiasis Health Product Research And Completed Suicide Professional Development ORAL 40:00 MG Decreased Appetite TOTAL:BID:ORA Depression L Fatigue Fluoxetin SS Intentional Overdose Propiomazin SS Uterine Leiomyoma Lithionit C Weight Decreased Bevitotal Comp C Alvedon C Losec Mups C Imovane C Apodorm C Date:03/12/01ISR Number: 3680847-XReport Type:Expedited (15-DaCompany Report #A103833 Age: Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Suicide Attempt Foreign Zeldox PS Pfizer Medicinal Initial or Prolonged Health Product Research And Professional Development ORAL 80.00 MG TOTAL:BID:ORA L Date:03/19/01ISR Number: 3684501-XReport Type:Expedited (15-DaCompany Report #A103833 Age:30 YR Gender:Male I/FU:F Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Suicide Attempt Foreign Zeldox PS Pfizer Medicinal Initial or Prolonged Health Product Research And Professional Development ORAL 160.00 MG TOTAL:BID:ORA L Hibernal C Fluanxol C Date:04/04/01ISR Number: 3696950-4Report Type:Direct Company Report # Age: Gender:Female I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Other Dizziness Geodon (Ziprazodone) Dyspnoea 40mg-Pfizer PS Pfizer ORAL 40MG PO BID Fatigue Lithium Heart Rate Increased Carbonate(Eskalith Syncope Cr) C Tremor 22-Feb-2006 08:32 AM Page: 2 FDA - Adverse Event Reporting System (AERS) Freedom Of Information (FOI) Report Date:04/05/01ISR Number: 3699931-XReport Type:Direct Company Report # Age:40 YR Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Other Electrocardiogram Qt Geodon / 20mg / Corrected Interval Pfizer Roerig PS Pfizer Roerig ORAL 20 MG BID Prolonged ORAL Electrocardiogram Qt Zyprexa C Prolonged Depakote C Artane C Lipitor C Captopril C Verapamil C Hct C Klor Conc C Asa C Date:04/09/01ISR Number: 3701761-7Report Type:Expedited (15-DaCompany Report #A106621 Age:17 YR Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Required Liver Function Test Consumer Zeldox PS Pfizer Medicinal Intervention to Abnormal Product Research And Prevent Permanent Development ORAL 80.00 MG Impairment/Damage TOTAL: BID: ORAL Haldol SS Zyprexa C Depakote C Serevent C Topamax C Zoloft C Prevacid C Flovent C Date:04/11/01ISR Number: 3702490-6Report Type:Direct Company Report # Age: Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Depressed Level Of Ziprasidone 80 Mg Initial or Prolonged Consciousness Pfizer PS ORAL 80 MG QD ORAL Medication Error Date:04/18/01ISR Number: 3707782-2Report Type:Expedited (15-DaCompany Report #A107567 Age:40 YR Gender:Female I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Bladder Disorder Foreign Ziprasidone PS Pfizer Medicinal Initial or Prolonged Constipation Consumer Product Research And Faecal Incontinence Development ORAL 40.00 MG Gastrointestinal Disorder TOTAL: BID: Urinary Incontinence ORAL Uterine Disorder 22-Feb-2006 08:32 AM Page: 3 FDA - Adverse Event Reporting System (AERS) Freedom Of Information (FOI) Report Date:04/19/01ISR Number: 3707346-0Report Type:Direct Company Report # Age:62 YR Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Required Atrioventricular Block Geodon 40 Mg Po Bid PS Pfizer ORAL 40MG PO BID Intervention to First Degree Lanoxin C Prevent Permanent Furosemide C Impairment/Damage Norvasc C Synthroid C Toprol C Buspar C Date:04/24/01ISR Number: 3710641-2Report Type:Expedited (15-DaCompany Report #A107567 Age:40 YR Gender:Female I/FU:F Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Anaemia Foreign Zeldox PS Pfizer Central Initial or Prolonged Blood Glucose Increased Consumer Research ORAL 40.00 MG Constipation TOTAL: BID: Diarrhoea ORAL Faecal Incontinence Insomnia Oedema Peripheral Urinary Incontinence Urinary Retention Uterine Enlargement Uterine Injury Uterine Leiomyoma Date:04/25/01ISR Number: 3711157-XReport Type:Expedited (15-DaCompany Report #10801926 Age:60 YR Gender:Female I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Anxiety Health Serzone PS Bristol Myers Squibb Initial or Prolonged Dizziness Professional Co Pharmaceutical Drug Interaction Research Institute ORAL 300 Nausea MILLIGRAM, 1 Palpitations DAY ORAL Panic Attack Geodon (Ziprasidone) SS 40 MILLIGRAM, Vomiting 1 DAY Xanax C Seroquel C Date:04/26/01ISR Number: 3711912-6Report Type:Expedited (15-DaCompany Report #A107661 Age:65 YR Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Required Agitation Health Geodon PS Pfizer Central Intervention to Anxiety Professional Research ORAL 40.00 MG Prevent Permanent Bundle Branch Block Right TOTAL BID Impairment/Damage Constipation ORAL Electrocardiogram Risperidone SS Abnormal Thorazine C Electrocardiogram Qt Asa C Prolonged Lorazepam C Insomnia Vitamin B12 C Pain Neutra-Phos C Lithium C Tylenol C 22-Feb-2006 08:32 AM Page: 4 FDA - Adverse Event Reporting System (AERS) Freedom Of Information (FOI) Report Cogentin C Chloral Hydrate C Mom With Cascara C Fleet Enema C Hydrocortisone C Sebulex C Olanzepine C Mevacor C Imodium C Phenolated Resorcinol C Terbinafine C Date:04/27/01ISR Number: 3713052-9Report Type:Direct Company Report # Age:40 YR Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Death Coronary Artery Disease Geodon (Ziprasidone) PS 2 WK Sudden Death Mellaril C Date:04/30/01ISR Number: 3714067-7Report Type:Expedited (15-DaCompany Report #A108439 Age:20 YR Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Mania Health Geodon PS Pfizer Central Initial or Prolonged Professional Research ORAL 80.00 MG Company TOTAL:BID:ORA Representative L Depakote (Divalproex Sodium) C Seroquel (Quetiapine Fumarate) C Topamax (Topiramate) C Date:04/30/01ISR Number: 3714230-5Report Type:Direct Company Report # Age:18 YR Gender:Female I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Required Agitation Geodon PS ORAL 40MG PO BID Intervention to Arthralgia Haldol C Prevent Permanent Blood Creatine Zyprexa C Impairment/Damage Phosphokinase Increased Seroquel C Leukocytosis Diazepam C Muscle Rigidity Pyrexia Sedation Tachycardia Tremor Date:05/01/01ISR Number: 3714709-6Report Type:Expedited (15-DaCompany Report #A108439 Age:20 YR Gender:Male I/FU:F Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Agitation Health Geodon PS Pfizer Central Initial or Prolonged Hallucination Professional Research ORAL 80.00 MG Mania Company TOTAL:BID:ORA Sedation Representative L 22-Feb-2006 08:32 AM Page: 5 FDA - Adverse Event Reporting System (AERS) Freedom Of Information (FOI) Report Depakote (Divalproex Sodium) C Seroquel (Quetiapine Fumarate) C Topamax (Topiramate) C Date:05/04/01ISR Number: 3717506-0Report Type:Direct Company Report # Age:8 YR Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Other Dyskinesia Ziprasidone PS ORAL 20 MG PO BID Muscle Twitching Date:05/04/01ISR Number: 3718396-2Report Type:Expedited (15-DaCompany Report #A109034 Age:37 YR Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Decreased Appetite Consumer Geodon PS Pfizer Central Initial or Prolonged Delusion Research ORAL 40.00 MG Drug Ineffective TOTAL: BID: Insomnia ORAL Zoloft C Date:05/04/01ISR Number: 3718403-7Report Type:Expedited (15-DaCompany Report #A109036 Age:43 YR Gender:Female I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Chest Pain Health Geodon PS Pfizer Central Initial or Prolonged Professional Research 80.00 MG TOTAL: BID Risperdal C Date:05/04/01ISR Number: 3733604-XReport Type:Periodic Company Report #A109516 Age: Gender:Unknown I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Other Dyspepsia Health Geodon PS Pfizer Central Nausea Professional Research Company Representative Date:05/07/01ISR Number: 3718074-XReport Type:Direct Company Report # Age:18 YR Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Death Aspiration Ziprasidone Convulsion (Geodon)-Roerig Loss Of Consciousness Division Of Pfizer PS Roering Division Of Vomiting Pfizer ORAL 20MG PO 1 CAPSULE PER DAY Clonidine C 22-Feb-2006 08:32 AM Page: 6 FDA - Adverse Event Reporting System (AERS) Freedom Of Information (FOI) Report Date:05/07/01ISR Number: 3718896-5Report Type:Expedited (15-DaCompany Report #A109100 Age:39 YR Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Required Papilloedema Health Geodon PS Pfizer Central Intervention to Professional Research ORAL 240.00 MG Prevent Permanent TOTAL:BID:ORA Impairment/Damage L Zyprexa C Zoloft C Aspirin C Date:05/07/01ISR Number: 3718898-9Report Type:Expedited (15-DaCompany Report #A109437 Age:71 YR Gender:Female I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Anticholinergic Syndrome Health Geodon PS Pfizer Central Initial or Prolonged Cerebrovascular Accident Professional Research 40.00 MG Movement Disorder Company TOTAL:BID Tongue Disorder Representative Perphenazine SS Amoxapine C Ativan C Klonopin C Zyprexa C Date:05/07/01ISR Number: 3718920-XReport Type:Expedited (15-DaCompany Report #A109110 Age:15 YR Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Agitation Consumer Geodon PS Pfizer Central Initial or Prolonged Crying Research ORAL 40.00 MG Fear TOTAL: BID: Hallucination ORAL Hallucination, Auditory Paxil C Hyperhidrosis Wellbutrin C Lithium C Zyrtec C Date:05/07/01ISR Number: 3718937-5Report Type:Expedited (15-DaCompany Report #A109368 Age: Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Chest Discomfort Health Geodon PS Pfizer Central Initial or Prolonged Chest Pain Professional Research Company Representative Date:05/07/01ISR Number: 3718938-7Report Type:Expedited (15-DaCompany Report #A109401 Age:48 YR Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Death Insomnia Health Geodon PS Pfizer Central Hospitalization - Myocardial Infarction Professional Research ORAL 80.00 MG Initial or Prolonged Sudden Death TOTAL: BID; ORAL Serentil SS Depakote C Neurontin C 22-Feb-2006 08:32 AM Page: 7 FDA - Adverse Event Reporting System (AERS) Freedom Of Information (FOI) Report Date:05/07/01ISR Number: 3719135-1Report Type:Expedited (15-DaCompany Report #A109319 Age:16 YR Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Required Dyskinesia Consumer Geodon PS Pfizer Central Intervention to Fall Research ORAL 140.00 MG Prevent Permanent Headache TOTAL:DAILY:O Impairment/Damage Muscle Spasms RAL Neck Pain Cogentin SS ORAL 1.50 MG TOTAL:TID:ORA L Aspirin C Date:05/08/01ISR Number: 3720196-4Report Type:Expedited (15-DaCompany Report #A109435 Age:33 YR Gender:Female I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Anxiety Health Geodon PS Pfizer Central Initial or Prolonged Asthenia Professional Research ORAL 40.00 MG Decreased Activity TOTAL BID Drug Interaction ORAL Dysarthria Effexor SS ORAL 300.00 MG Gait Disturbance TOTAL DAILY Headache ORAL Hyperhidrosis Aldactone C Insomnia Risperidone C Nausea Restlessness Stress Suicidal Ideation Date:05/08/01ISR Number: 3720198-8Report Type:Expedited (15-DaCompany Report #A108646 Age:25 YR Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Irritability Consumer Geodon PS Pfizer Central Initial or Prolonged Mania Research ORAL 80.00 MG TOTAL BID ORAL Seroquel SS ORAL 300.00 MG TOTAL DAILY ORAL Depakote C Neurontin C Clonazepam C Date:05/08/01ISR Number: 3720200-3Report Type:Expedited (15-DaCompany Report #A109539 Age:84 YR Gender:Female I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Agitation Health Geodon PS Pfizer Central Initial or Prolonged Coma Professional Research 40.00 MG Electrocardiogram Company TOTAL BID Abnormal Representative B12 Injection C Hypotension 22-Feb-2006 08:32 AM Page: 8 FDA - Adverse Event Reporting System (AERS) Freedom Of Information (FOI) Report Date:05/10/01ISR Number: 3720681-5Report Type:Direct Company Report # Age:43 YR Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Serotonin Syndrome Geodon 20mg PS ORAL 2TT QD PO Initial or Prolonged Luvox 100mg SS ORAL 2TT QD PO Prinivil C Cogentin C Dextrol C Singular C Date:05/10/01ISR Number: 3720706-7Report Type:Expedited (15-DaCompany Report #A109107 Age:42 YR Gender:Female I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Abdominal Pain Consumer Geodon PS Pfizer Central Initial or Prolonged Abdominal Pain Upper Health Research INTRAVENOUS Required Anhedonia Professional Trazodone SS Intervention to Anxiety Venlafaxine SS ORAL ORAL Prevent Permanent Cough Lorazepam SS ORAL ORAL Impairment/Damage Decreased Appetite Aleve C Depression Welbutrin C Diarrhoea Zyprexa C Diplopia Humid C Disturbance In Attention Ascorbic Acid C Electrocardiogram Qt Demadex C Corrected Interval Glucotrol Xl C Prolonged Insulin C Fatigue Indocin C Feelings Of Worthlessness Albuterol C Flat Affect Simvastatin C Hallucination, Auditory Cetirizine C Hallucination, Tactile Dobutamine C Headache Guaifenesin C Intentional Overdose Lansoprazole C Lethargy Potassium Chloride C Nausea Sodium Chloride C Nightmare Torsemide C Psychomotor Retardation Dopamine C Sedation Propofol C Self Mutilation Bisacodyl C Social Avoidant Behaviour Gentamycin C Suicidal Ideation Fluconazole C Vision Blurred Metoclopramide C Triamterene C Acetaminophen C Cisapride C Zinc Sulfate C Platelet C Fentanyl C Morepinephrine C Leukocyte Poor Prbcs C Acetazolamide C Propoxyphene/Acetami nophen C Magnesium Sulfate C Sodium Bicarbonate C Nitroglycerine C Milrinone C Packed Rbcs C Aztreonam C 22-Feb-2006 08:32 AM Page: 9 FDA - Adverse Event Reporting System (AERS) Freedom Of Information (FOI) Report Furosemide C Hetastarch C Isorbide Mononitrate C Vancomycin C Lactated Ringers C Calcium Chloride C Cetacaine C Clindamycin C Fresh Frozen Plasma C Isoflurane C Date:05/11/01ISR Number: 3721890-1Report Type:Expedited (15-DaCompany Report #A109802 Age:45 YR Gender:Female I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Abnormal Behaviour Health Geodon PS Pfizer Central Initial or Prolonged Fall Professional Research ORAL ORAL Hallucination, Auditory Seroquel C Muscle Rigidity Klonopin C Muscle Twitching Propranolol C Tongue Discolouration Paxil C Tongue Disorder Nortriptyline C Tremor Lithium C Date:05/11/01ISR Number: 3721901-3Report Type:Expedited (15-DaCompany Report #A109905 Age: Gender: I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Required Neuroleptic Malignant Health Geodon PS Pfizer Central Intervention to Syndrome Professional Research Prevent Permanent Company Impairment/Damage Representative Date:05/11/01ISR Number: 3721903-7Report Type:Expedited (15-DaCompany Report #A109864 Age:17 YR Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Death Aspiration Health Geodon PS Pfizer Central Required Convulsion Professional Research ORAL 20.00 MG Intervention to Nausea TOTAL:DAILY:O Prevent Permanent RAL Impairment/Damage Clonidine C Date:05/14/01ISR Number: 3723774-1Report Type:Expedited (15-DaCompany Report #A110024 Age: Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Aggression Health Geodon PS Pfizer Central Initial or Prolonged Impulsive Behaviour Professional Research ORAL 80.00 MG Sexual Dysfunction Company TOTAL; DAILY; Representative ORAL 22-Feb-2006 08:32 AM Page: 10 FDA - Adverse Event Reporting System (AERS) Freedom Of Information (FOI) Report Date:05/15/01ISR Number: 3723521-3Report Type:Expedited (15-DaCompany Report #A109401 Age:48 YR Gender:Male I/FU:F Outcome PT Report Source Product Role Manufacturer Route Dose Duration Death Insomnia Health Geodon PS Pfizer Central Hospitalization - Myocardial Infarction Professional Research ORAL 80.00 MG Initial or Prolonged Sudden Death Company TOTAL:BID:ORA Representative L Serentil SS Depakote C Neurontin C Date:05/15/01ISR Number: 3723528-6Report Type:Expedited (15-DaCompany Report #A110170 Age: Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Aggression Health Geodon PS Pfizer Central Initial or Prolonged Drug Ineffective Professional Research 80.00 MG Required Erythema TOTAL; BID Intervention to Grand Mal Convulsion Haldol C Prevent Permanent Hyperhidrosis Zantac C Impairment/Damage Hypertension Nausea Oxygen Saturation Decreased Tachycardia Vomiting Date:05/15/01ISR Number: 3723712-1Report Type:Expedited (15-DaCompany Report #A109107 Age:42 YR Gender:Female I/FU:F Outcome PT Hospitalization - Abdominal Pain Initial or Prolonged Abdominal Pain Upper Required Abdominal Tenderness Intervention to Anhedonia Prevent Permanent Anxiety Impairment/Damage Cough Decreased Activity Dependent Personality Disorder Diarrhoea Diplopia Disturbance In Attention Dizziness Drug Level Above Therapeutic Dyspepsia Dysphoria Electrocardiogram Abnormal Faecal Incontinence Feelings Of Worthlessness Flat Affect Hallucination, Auditory Hallucination, Synaesthetic Headache Insomnia Intentional Overdose 22-Feb-2006 08:32 AM Page: 11 FDA - Adverse Event Reporting System (AERS) Freedom Of Information (FOI) Report Lethargy Nausea Neglect Of Personal Report Source Product Role Manufacturer Route Dose Duration Appearance Consumer Geodon PS Pfizer Central Nightmare Health Research Sedation Professional Trazodone SS Social Avoidant Behaviour Venlafaxine SS ORAL ORAL Urinary Incontinence Lorazepam SS ORAL ORAL Vision Blurred Aleve C Welbutrin C Zyprexa C Date:05/15/01ISR Number: 3723713-3Report Type:Expedited (15-DaCompany Report #A109539 Age:84 YR Gender:Female I/FU:F Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Coma Health Geodon PS Pfizer Central Initial or Prolonged Hypotension Professional Research ORAL 40.00 MG Pulse Pressure Decreased TOTAL:BID:ORA L Vitamin B12 Injection C Date:05/16/01ISR Number: 3724893-6Report Type:Expedited (15-DaCompany Report #A109850 Age: Gender:Unknown I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Death Death Health Geodon PS Pfizer Central Professional Research Date:05/16/01ISR Number: 3724896-1Report Type:Expedited (15-DaCompany Report #A109961 Age: Gender:Unknown I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Required Neuroleptic Malignant Health Geodon PS Pfizer Central Intervention to Syndrome Professional Research Prevent Permanent Company Impairment/Damage Representative Date:05/16/01ISR Number: 3725030-4Report Type:Expedited (15-DaCompany Report #A110322 Age: Gender: I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Death Death Health Geodon PS Pfizer Central Professional Research Mellaril SS Date:05/16/01ISR Number: 3725031-6Report Type:Expedited (15-DaCompany Report #A109882 Age:18 YR Gender:Female I/FU:I Outcome PT Required Arthralgia Intervention to Blood Creatine Prevent Permanent Phosphokinase Increased Impairment/Damage Neuroleptic Malignant Syndrome 22-Feb-2006 08:32 AM Page: 12 FDA - Adverse Event Reporting System (AERS) Freedom Of Information (FOI) Report Sedation Tachycardia Report Source Product Role Manufacturer Route Dose Duration Health Geodon PS Pfizer Central Professional Research Haldol C Zyprexa C Seroquel C Diazepam C Date:05/17/01ISR Number: 3724693-7Report Type:Expedited (15-DaCompany Report #A109850 Age: Gender: I/FU:F Outcome PT Report Source Product Role Manufacturer Route Dose Duration Death Death Health Geodon PS Pfizer Central Professional Research Date:05/18/01ISR Number: 3725577-0Report Type:Expedited (15-DaCompany Report #A109401 Age:47 YR Gender:Male I/FU:F Outcome PT Report Source Product Role Manufacturer Route Dose Duration Death Blood Glucose Increased Consumer Geodon PS Pfizer Central Hospitalization - Hypertension Health Research ORAL 20.00 MG Initial or Prolonged Insomnia Professional TOTAL:BID:ORA Insulin Resistance Company L Obesity Representative Serentil SS Osteoarthritis Depakote C Seborrhoea Neurontin C Sudden Death Atorvastatin C Remeron C Klonepin C Date:05/21/01ISR Number: 3726385-7Report Type:Expedited (15-DaCompany Report #A109377 Age:86 YR Gender:Female I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Electrocardiogram Qt Health Geodon PS Pfizer Central Initial or Prolonged Corrected Interval Professional Research ORAL 60.00 MG Required Prolonged TOTAL:BID:ORA Intervention to Electrocardiogram Qt L Prevent Permanent Prolonged ... C Impairment/Damage Mental Impairment Sedation Date:05/22/01ISR Number: 3727194-5Report Type:Expedited (15-DaCompany Report #001-0981-M0103661 Age:47 YR Gender: I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Unevaluable Event Health Lipitor PS Pfizer Inc ORAL 10 MG (BID), Initial or Prolonged Professional PER ORAL (Gabapentin) SS ORAL 1200 MG (EVERY AM)'600 MG (EVERY NOON); 1200 MG (Geodon) SS ORAL 40 MG (DAILY);4O MG 22-Feb-2006 08:32 AM Page: 13 FDA - Adverse Event Reporting System (AERS) Freedom Of Information (FOI) Report (BID);40 MG (DAILY); 20 MG (DAILY), (Acetylsalicylic Acid) SS ORAL 325 MG (DAILY), PER ORAL (Chlorpromazine) SS ORAL 100 MG (EVERY 4 HOURS PRN), PER ORAL (Clonazepam) SS ORAL 2 MG (AT BEDTIME), PER ORAL (Lorazepam) SS ORAL 2 MG (EVERY 6 HOURS); 2 MG (EVERY 4 HR PRN), PER ORAL (Mesoridazine) SS ORAL 50 MG (DAILY);75 MG (BID);75 MG (TID); 50 MG (EVERY 4 (Mirtazapine) SS ORAL 15 MG (AT BEDTIME), PER ORAL Date:05/22/01ISR Number: 3727618-3Report Type:Direct Company Report # Age:44 YR Gender:Female I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Required Agitation Geodon 20mg Pfizer PS Pfizer ORAL ONE CAPSU AT Intervention to Anxiety BED TIME ORAL Prevent Permanent Chest Pain Impairment/Damage Hyperhidrosis Date:05/23/01ISR Number: 3727876-5Report Type:Expedited (15-DaCompany Report #A110764 Age:43 YR Gender:Female I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Dizziness Health Geodon PS Pfizer Central Initial or Prolonged Drug Effect Decreased Professional Research UNKNOWN 40.00 MG TOTAL:BID:UNK NOWN Prolixin (Fluphenazine) C Prozac (Fluoxetine) C Serevent (Salmeterol) C Tegretol (Carbamazepine) C Calcium Supplement C Verapamil C Valproic Acid C 22-Feb-2006 08:32 AM Page: 14 FDA - Adverse Event Reporting System (AERS) Freedom Of Information (FOI) Report Date:05/23/01ISR Number: 3727877-7Report Type:Expedited (15-DaCompany Report #A110761 Age:53 YR Gender:Female I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Depression Health Geodon PS Pfizer Central Initial or Prolonged Liver Function Test Professional Research ORAL 80.00 MG Abnormal TOTAL:BID:ORA L Pravachol C Anafranil (Clomipramine) C Clonazepam C Effexor (Venlafaxine) C Risperidone C Os-Cal 500 C Date:05/23/01ISR Number: 3727880-7Report Type:Expedited (15-DaCompany Report #A110766 Age: Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Confusional State Consumer Geodon PS Pfizer Central Initial or Prolonged Disorientation Research 80.00 MG Malaise TOTAL BID Atenolol C Date:05/23/01ISR Number: 3727886-8Report Type:Expedited (15-DaCompany Report #A109864 Age:17 YR Gender:Male I/FU:F Outcome PT Report Source Product Role Manufacturer Route Dose Duration Death Aspiration Health Geodon PS Pfizer Central Required Convulsion Professional Research ORAL 20.00 MG Intervention to Nausea TOTAL DAILY Prevent Permanent ORAL Impairment/Damage Clonidine C Date:05/23/01ISR Number: 3727887-XReport Type:Expedited (15-DaCompany Report #A108646 Age:25 YR Gender:Male I/FU:F Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Mania Consumer Geodon PS Pfizer Central Initial or Prolonged Medication Error Health Research ORAL ORAL Schizophrenia Professional Seroquel SS ORAL 300.00 MG TOTAL DAILY ORAL Neurontin (Gabapentin) SS 3600.00 MG TOTAL TID Beer SS ORAL ORAL Depakote C Clonazepam C Date:05/25/01ISR Number: 3728889-XReport Type:Expedited (15-DaCompany Report #A109850 Age:80 YR Gender:Male I/FU:F Outcome PT Report Source Product Role Manufacturer Route Dose Duration Death Death Health Geodon PS Pfizer Central Life-Threatening Professional Research ORAL 80.00 MG 22-Feb-2006 08:32 AM Page: 15 FDA - Adverse Event Reporting System (AERS) Freedom Of Information (FOI) Report TOTAL:BID:ORA L Lasix C Potassium C Vitamin C Folic Acid C Date:05/25/01ISR Number: 3728891-8Report Type:Expedited (15-DaCompany Report #A109401 Age:47 YR Gender:Male I/FU:F Outcome PT Report Source Product Role Manufacturer Route Dose Duration Death Insomnia Consumer Geodon PS Pfizer Central Hospitalization - Sudden Death Health Research ORAL 20.00 MG Initial or Prolonged Professional TOTAL:DAILY:O RAL Serentil SS ORAL 225.00 MG TOTAL:TID:ORA L Neurontin C Atorvastatin C Remeron C Klonopin C Aspirin C Thorazine C Lorazepam C Cogentin C Depakote C Prinivil C Moban C Zyprexa C Seroquel C Prozac C Date:05/25/01ISR Number: 3730495-8Report Type:Expedited (15-DaCompany Report #A109107 Age:42 YR Gender:Female I/FU:F Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Abdominal Pain Consumer Geodon PS Pfizer Central Initial or Prolonged Abdominal Tenderness Health Research 4360.00 MG Required Anhedonia Professional TOTAL Intervention to Anxiety Trazodone SS 800.00 MG Prevent Permanent Body Temperature TOTAL Impairment/Damage Decreased Venlafaxine SS ORAL 2400.00 MG Condition Aggravated TOTAL:ORAL Depression Lorazepam SS ORAL ORAL Diplopia Aleve C Disturbance In Attention Wellbutrin C Electrocardiogram Qt Zyprexa C Corrected Interval Prolonged Hallucination, Auditory Insomnia Intentional Overdose Intentional Self-Injury Laceration Lethargy Oral Intake Reduced Sedation Social Avoidant Behaviour Suicidal Ideation 22-Feb-2006 08:32 AM Page: 16 FDA - Adverse Event Reporting System (AERS) Freedom Of Information (FOI) Report Date:05/29/01ISR Number: 3729944-0Report Type:Expedited (15-DaCompany Report #A110766 Age: Gender:Male I/FU:F Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Confusional State Consumer Geodon PS Pfizer Central Initial or Prolonged Disorientation Research 60.00 MG Malaise TOTAL; BID Restlessness Atenolol C Date:05/29/01ISR Number: 3729980-4Report Type:Expedited (15-DaCompany Report #A110980 Age:45 YR Gender:Female I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Life-Threatening Abdominal Distension Consumer Geodon PS Pfizer Central Anxiety Research ORAL 40.00 MG Arrhythmia TOTAL BID Blood Pressure Increased ORAL Cardiac Arrest Synthroid C Dizziness Estratest C Electrocardiogram Qt Effexor C Prolonged Prevacid C Electrocardiogram T Wave Inversion Extrasystoles Heart Rate Increased Loss Of Consciousness Palpitations Syncope Ventricular Tachycardia Date:05/29/01ISR Number: 3730076-6Report Type:Expedited (15-DaCompany Report #A110982 Age:16 YR Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Bradycardia Health Geodon PS Pfizer Central Initial or Prolonged Professional Research UNKNOWN UNKNOWN; UNKNOWN Date:05/30/01ISR Number: 3729693-9Report Type:Direct Company Report # Age: Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Dystonia Geodon Ziprasidone Initial or Prolonged 20mg Pfizer PS Pfizer ORAL 20MG BID ORAL Required Intervention to Prevent Permanent Impairment/Damage Date:05/30/01ISR Number: 3730633-7Report Type:Expedited (15-DaCompany Report #A111153 Age: Gender:Female I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Inappropriate Foreign Geodon PS Pfizer Central Initial or Prolonged Antidiuretic Hormone Health Research ORAL ORAL Secretion Professional Tegretol SS ORAL ORAL Zopliclone SS Nitrazepam SS 22-Feb-2006 08:32 AM Page: 17 FDA - Adverse Event Reporting System (AERS) Freedom Of Information (FOI) Report Stesolid C Date:05/30/01ISR Number: 3730936-6Report Type:Expedited (15-DaCompany Report #A111003 Age:18 YR Gender:Female I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Alanine Aminotransferase Consumer Geodon PS Pfizer Central Initial or Prolonged Increased Research BID Required Aspartate Ritalin Sr C Intervention to Aminotransferase Seroquel C Prevent Permanent Increased Aleve C Impairment/Damage Convulsion Dysphagia Headache Infectious Mononucleosis Lymphocyte Count Increased Muscle Rigidity Myalgia Oxygen Saturation Decreased Pharyngolaryngeal Pain Pyrexia Date:05/30/01ISR Number: 3730937-8Report Type:Expedited (15-DaCompany Report #A111431 Age:33 YR Gender:Female I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Other Arrhythmia Health Geodon PS Pfizer Central Electrocardiogram Qt Professional Research Corrected Interval Company Ativan (Lorazepam) C Prolonged Representative Date:05/30/01ISR Number: 3730953-6Report Type:Expedited (15-DaCompany Report #A108295 Age:43 YR Gender:Female I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Anxiety Health Geodon PS Pfizer Central Initial or Prolonged Chest Pain Professional Research Required Heart Rate Increased Risperidone SS Intervention to Panic Attack Prevent Permanent Impairment/Damage Date:05/30/01ISR Number: 3731169-XReport Type:Expedited (15-DaCompany Report #A109850 Age:80 YR Gender:Male I/FU:F Outcome PT Report Source Product Role Manufacturer Route Dose Duration Death Agitation Health Geodon PS Pfizer Central Life-Threatening Confusional State Professional Research ORAL 80.00 MG Dementia Alzheimer'S Type TOTAL:BID:ORA Sudden Death L Tremor Lasix C Potassium C Vitamin C Folic Acid C 22-Feb-2006 08:32 AM Page: 18 FDA - Adverse Event Reporting System (AERS) Freedom Of Information (FOI) Report Date:05/30/01ISR Number: 3731172-XReport Type:Expedited (15-DaCompany Report #A109401 Age:47 YR Gender:Male I/FU:F Outcome PT Report Source Product Role Manufacturer Route Dose Duration Death Agitation Consumer Geodon PS Pfizer Central Hospitalization - Blood Glucose Increased Health Research ORAL 80.00 MG Initial or Prolonged Insomnia Professional TOTAL:DAILY:O Psychotic Disorder Company RAL Sudden Death Representative Serentil SS ORAL 225.00 MG TOTAL:TID:ORA L Neurontin C Atorvastatin C Remeron C Klonopin C Aspirin C Thorazine C Lorazepam C Cogentin C Depakote C Prinivil C Moban C Zyprexa C Seroquel C Prozac C Date:06/01/01ISR Number: 3732124-6Report Type:Expedited (15-DaCompany Report #A111635 Age: Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Other Convulsion Health Geodon PS Pfizer Central Loss Of Consciousness Professional Research ORAL ORAL Medication Error Company Unspecified Overdose Representative Medications SS Suicide Attempt Luvox C Date:06/01/01ISR Number: 3732126-XReport Type:Expedited (15-DaCompany Report #A111562 Age:43 YR Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Psychotic Disorder Consumer Geodon PS Pfizer Central Initial or Prolonged Research ORAL 120.00 MG TOTAL; BID; ORAL Neurontin (Gabapentin) C Date:06/01/01ISR Number: 3732128-3Report Type:Expedited (15-DaCompany Report #A111507 Age: Gender: I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Other Hypotension Health Geodon PS Pfizer Central Syncope Professional Research ORAL UNKNOWN; ORAL Company Representative 22-Feb-2006 08:32 AM Page: 19 FDA - Adverse Event Reporting System (AERS) Freedom Of Information (FOI) Report Date:06/01/01ISR Number: 3732136-2Report Type:Expedited (15-DaCompany Report #A110764 Age:43 YR Gender:Female I/FU:F Outcome PT Report Source Product Role Manufacturer Route Dose Duration Hospitalization - Dizziness Health Geodon PS Pfizer Central Initial or Prolonged Drug Effect Decreased Professional Research ORAL PO Electrocardiogram Prolixin Abnormal (Fluphenazine) C Prozac (Fluoxetine) C Serevent (Salmeterol) C Tegretol (Carbamazepine) C Calcium Supplement C Verapamil C Valproic Acid C Date:06/01/01ISR Number: 3732141-6Report Type:Expedited (15-DaCompany Report #A111396 Age: Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Required Grand Mal Convulsion Health Geodon PS Pfizer Central Intervention to Professional Research Prevent Permanent Lithium C Impairment/Damage Paxil C Unknown Blood Pressure Medication C Date:06/04/01ISR Number: 3733045-5Report Type:Expedited (15-DaCompany Report #A111507 Age: Gender:Unknown I/FU:F Outcome PT Report Source Product Role Manufacturer Route Dose Duration Other Orthostatic Hypotension Health Geodon PS Pfizer Central Syncope Professional Research ORAL ORAL Company Representative Date:06/04/01ISR Number: 3733424-6Report Type:Periodic Company Report #A109385 Age:18 YR Gender:Female I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Other Insomnia Health Geodon PS Pfizer Central Mania Professional Research 20.00 MG Sedation Company TOTAL:DAILY Representative Date:06/04/01ISR Number: 3733425-8Report Type:Periodic Company Report #A109386 Age:10 YR Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Other Chest Pain Health Geodon PS Pfizer Central Dyspnoea Professional Research Company Representative 22-Feb-2006 08:32 AM Page: 20 FDA - Adverse Event Reporting System (AERS) Freedom Of Information (FOI) Report Date:06/04/01ISR Number: 3733426-XReport Type:Periodic Company Report #A109387 Age:16 YR Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Other Hyperhidrosis Health Geodon PS Pfizer Central Nausea Professional Research 60.00 MG Sedation Company TOTAL:BID Representative Date:06/04/01ISR Number: 3733427-1Report Type:Periodic Company Report #A109388 Age:11 YR Gender:Female I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Other Drug Ineffective Health Geodon PS Pfizer Central Dyskinesia Professional Research 80.00 MG Company TOTAL:BID Representative Date:06/04/01ISR Number: 3733428-3Report Type:Periodic Company Report #A109389 Age: Gender:Unknown I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Other Extrapyramidal Disorder Health Geodon PS Pfizer Central Professional Research Company Representative Date:06/04/01ISR Number: 3733429-5Report Type:Periodic Company Report #A109415 Age:44 YR Gender:Female I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Other Depression Consumer Geodon PS Pfizer Central Research ORAL 20.00 MG TOTAL:DAILY:O RAL Premarin C Prilosec C Date:06/04/01ISR Number: 3733430-1Report Type:Periodic Company Report #A109425 Age: Gender:Female I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Other Headache Health Geodon PS Pfizer Central Nausea Professional Research ORAL 40.00 MG Company TOTAL:BID:ORA Representative L Topamax C Lithium C Date:06/04/01ISR Number: 3733431-3Report Type:Periodic Company Report #A109439 Age: Gender:Female I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Other Dizziness Health Geodon PS Pfizer Central Visual Disturbance Professional Research ORAL 20.00 MG Company TOTAL:DAILY:O Representative RAL 22-Feb-2006 08:32 AM Page: 21 FDA - Adverse Event Reporting System (AERS) Freedom Of Information (FOI) Report Seroquel C Effexor C Risperdal C Date:06/04/01ISR Number: 3733432-5Report Type:Periodic Company Report #A109441 Age:19 YR Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Other Weight Increased Consumer Geodon PS Pfizer Central Research 80.00 MG TOTAL:DAILY Accutane C Zoloft C Risperdal C Date:06/04/01ISR Number: 3733433-7Report Type:Periodic Company Report #A109443 Age:27 YR Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Other Dermatitis Health Geodon PS Pfizer Central Professional Research 80.00 MG TOTAL:BID Depakote C Wellbutrin C Klonopin C Date:06/04/01ISR Number: 3733434-9Report Type:Periodic Company Report #A108437 Age: Gender: I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Other Diarrhoea Health Geodon PS Pfizer Central Palpitations Professional Research Company Representative Date:06/04/01ISR Number: 3733435-0Report Type:Periodic Company Report #A108440 Age:12 YR Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Other Mania Health Geodon PS Pfizer Central Professional Research ORAL 100.00 MG Company TOTAL:BID:ORA Representative L Depakote (Divalproex Sodium) C Zyprexa (Olanzapine) C Date:06/04/01ISR Number: 3733436-2Report Type:Periodic Company Report #A108458 Age: Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Other Bradycardia Health Geodon PS Pfizer Central Professional Research 22-Feb-2006 08:32 AM Page: 22 FDA - Adverse Event Reporting System (AERS) Freedom Of Information (FOI) Report Date:06/04/01ISR Number: 3733437-4Report Type:Periodic Company Report #A108467 Age:59 YR Gender:Female I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Other Amnesia Consumer Geodon PS Pfizer Central Coordination Abnormal Research ORAL 40.00 MG Depression TOTAL: Dizziness DAILY:ORAL Personality Disorder Effexor C Sedation Synthroid C Thinking Abnormal Cytomel C Progesterone C Ativan C Vitamins C Trazodone C Cozaar C Klonopin C Date:06/04/01ISR Number: 3733438-6Report Type:Periodic Company Report #A108470 Age:8 YR Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Other Bipolar I Disorder Consumer Geodon PS Pfizer Central Research 40.00 MG TOTAL:BID Risperdal C Depakote C Lithium C Wellbutrin C Date:06/04/01ISR Number: 3733439-8Report Type:Periodic Company Report #A108484 Age: Gender:Male I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Other Hypersensitivity Consumer Geodon PS Pfizer Central Research ORAL ORAL Date:06/04/01ISR Number: 3733440-4Report Type:Periodic Company Report #A108538 Age: Gender: I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Other Tremor Health Geodon PS Pfizer Central Professional Research Company Representative Date:06/04/01ISR Number: 3733441-6Report Type:Periodic Company Report #A108577 Age: Gender:Female I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Other Hypocalcaemia Health Geodon PS Pfizer Central Professional Research Calcium C 22-Feb-2006 08:32 AM Page: 23 FDA - Adverse Event Reporting System (AERS) Freedom Of Information (FOI) Report Date:06/04/01ISR Number: 3733442-8Report Type:Periodic Company Report #A108581 Age: Gender:Female I/FU:I Outcome PT Report Source Product Role Manufacturer Route Dose Duration Other Anxiety Health Geodon PS Pfizer Central Drug Interaction Professional Research ORAL 150.00 MG TOTAL:BID:ORA L Wellbutrin SS